PMID- 12096201 OWN - NLM STAT- MEDLINE DCOM- 20020801 LR - 20220321 IS - 0040-6376 (Print) IS - 1468-3296 (Electronic) IS - 0040-6376 (Linking) VI - 57 IP - 7 DP - 2002 Jul TI - Increased levels of the chemokines GROalpha and MCP-1 in sputum samples from patients with COPD. PG - 590-5 AB - BACKGROUND: Patients with chronic obstructive pulmonary disease (COPD) have increased numbers of neutrophils and macrophages in their lungs. Growth related oncogene-alpha (GROalpha) attracts neutrophils, whereas monocyte chemoattractant protein-1 (MCP-1) attracts monocytes that can differentiate into macrophages. The aim of this study was to determine the concentration of GROalpha and MCP-1 in bronchoalveolar lavage (BAL) fluid and sputum from non-smokers, healthy smokers and patients with COPD, and to see if there was a correlation between the concentrations of these chemokines, lung function, and numbers of inflammatory cells. METHODS: BAL fluid and sputum from non-smokers (n=32), healthy smokers (n=36), and patients with COPD (n=40) were analysed for the presence of GROalpha and MCP-1 using ELISA. Cells counts were performed on the samples and correlations between the concentrations of these chemokines, lung function, and inflammatory cells observed. RESULTS: Median (SE) GROalpha and MCP-1 levels were significantly increased in sputum from patients with COPD compared with non-smokers and healthy smokers (GROalpha: 31 (11) v 2 (2) v 3 (0.8) ng/ml; MCP-1: 0.8 (0.4) v 0.2 (0.1) v 0.1 (0.04) ng/ml, p<0.05), but not in BAL fluid. There were significant negative correlations between both GROalpha and MCP-1 levels in sputum and forced expiratory volume in 1 second (FEV(1)) % predicted (GROalpha: r=-0.5, p<0.001; MCP-1: r=-0.5, p<0.001), together with significant positive correlations between GROalpha and MCP-1 and neutrophil numbers in sputum (GROalpha: r=0.6, p<0.001; MCP-1: r=0.4, p<0.01). CONCLUSION: These results suggest that GROalpha and MCP-1 are involved in the migration of inflammatory cells, thus contributing to the inflammatory load associated with COPD. FAU - Traves, S L AU - Traves SL AD - Department of Thoracic Medicine, National Heart and Lung Institute, Imperial College, School of Medicine, Dovehouse Street, London SW3 6LY, UK. FAU - Culpitt, S V AU - Culpitt SV FAU - Russell, R E K AU - Russell RE FAU - Barnes, P J AU - Barnes PJ FAU - Donnelly, L E AU - Donnelly LE LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Thorax JT - Thorax JID - 0417353 RN - 0 (Biomarkers) RN - 0 (CXCL1 protein, human) RN - 0 (Chemokine CCL2) RN - 0 (Chemokine CXCL1) RN - 0 (Chemokines, CXC) RN - 0 (Chemotactic Factors) RN - 0 (Growth Substances) RN - 0 (Intercellular Signaling Peptides and Proteins) SB - IM MH - Adult MH - Biomarkers MH - Bronchoalveolar Lavage Fluid/cytology MH - Cell Count MH - Chemokine CCL2/*metabolism MH - Chemokine CXCL1 MH - *Chemokines, CXC MH - Chemotactic Factors/*metabolism MH - Female MH - Forced Expiratory Volume/physiology MH - Growth Substances/*metabolism MH - Humans MH - *Intercellular Signaling Peptides and Proteins MH - Macrophages/chemistry MH - Male MH - Middle Aged MH - Neutrophils/chemistry MH - Pulmonary Disease, Chronic Obstructive/*etiology/metabolism MH - Smoking/metabolism MH - Sputum/cytology/*metabolism PMC - PMC1746378 EDAT- 2002/07/04 10:00 MHDA- 2002/08/02 10:01 PMCR- 2005/07/01 CRDT- 2002/07/04 10:00 PHST- 2002/07/04 10:00 [pubmed] PHST- 2002/08/02 10:01 [medline] PHST- 2002/07/04 10:00 [entrez] PHST- 2005/07/01 00:00 [pmc-release] AID - 10.1136/thorax.57.7.590 [doi] PST - ppublish SO - Thorax. 2002 Jul;57(7):590-5. doi: 10.1136/thorax.57.7.590.